Back

Preprocedural global myocardial work index independently predicts NT-proBNP in patients undergoing transcatheter aortic valve replacement: a prospective study

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Novel echocardiographic indices of ventricular performance Systolic and Diastolic Function ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Balint Karoly Lakatos

Semmelweis University, Budapest (Hungary)

4 More presentations in this session

Presentation thumbnail
Association between left atrial coupling index by echocardiography and left ventricular end diastolic pressure by left ventricular catheterization
Ms K. Ravnkilde (Gentofte, DK)
Abstract Slides Video
Presentation thumbnail
Significant disagreements between conventional functional metrics and 3D echocardiography-derived ejection fraction in the detection of right ventricular systolic dysfunction
Mr M. Tolvaj (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Diagnostic accuracy of apical sparing pattern in transthyretin-derived cardiac amyloidosis assessed by two-dimensional strain echocardiography
Doctor W. Suzuki (Aichi, JP)
Abstract Slides Video
Presentation thumbnail
Prognostic implications of right ventricular systolic and diastolic strain in heart failure
Doctor M. Matshela (Durban, ZA)
Abstract Slides Video

Access the full session

Session thumbnail
Novel echocardiographic indices of ventricular performance

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Pressure-volume-strain-derived myocardial work: a novel prognostic marker in patients undergoing transcatheter aortic valve replacement
thumbnail
Congress Presentation
Difference in the myocardial work value between the groups of symptomatic severe aortic stenosis according to the AHA classification
thumbnail
Congress Presentation
Prognostic impact of left atrial and ventricular strain coupling after TAVR: a novel risk assessment approach

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources